NCT01627704View on ClinicalTrials.gov

Fluoroestradiol PET Imaging in Predicting Response to Hormone Therapy of Breast Cancer

NACompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

June 30, 2012

Primary Completion Date

January 31, 2015

Study Completion Date

January 31, 2015

Conditions
Metastatic Breast Cancer
Interventions
DRUG

Fluoroestradiol (18F)

2-4 MBq/kg body mass, one single IV injection

Trial Locations (1)

75020

Service de Médecine Nucléaire, Hôpital Tenon, Paris

All Listed Sponsors
lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT01627704 - Fluoroestradiol PET Imaging in Predicting Response to Hormone Therapy of Breast Cancer | Biotech Hunter | Biotech Hunter